Genomenon

Genomenon specializes in providing actionable genomic evidence at the gene and variant level, aligned with ACMG/AMP guidelines, to support patient diagnosis and precision medicine for rare diseases and cancer. Their services cater to biopharma and clinical labs, offering real-world evidence, genetic disease sponsorship, and software solutions for v... ariant interpretation. The company utilizes AI to analyze and curate extensive biomedical literature, enabling confident decision-making based on comprehensive evidence. Genomenon's platforms, including the Cancer Knowledgebase, facilitate faster diagnoses and broader patient eligibility for drug programs.Read More